|
Full Length
Research Paper
|
|
Multiple mutations in the
rpoB gene of Mycobacterium tuberculosis
isolates correlate with high level of resistance to
rifampicin in patients with active pulmonary tuberculosis in
Afghanistan border of Iran
Saeed Zaker Bostanabad1, 3*, Mohammad
Noghanian3, A. Edward Graviss2, Ahmad
Reza Bahrmand1, P. Leonid Titov3 and
Seyed Ali Nojoumi1
1Molecular
Genetic laboratory of Mycobacteria, Department of
Mycobacteriology, Pasteur Institute of Iran, Pasture Ave,
Tehran, 13164, Iran.
2Pathology
Department, Baylor College of Medicine, Houston, Texas.
3Belarusian
Research of Epidemiology and Microbiology, Clinical
Microbiology, Belarus.
*Corresponding author. E-mail:
Saeedzaker20@yahoo.com.
Accepted
18 March, 2008 |
|
|
|
Abstract |
|
|
|
The aim of
this study was to investigate the significance of multiple
mutations in the rpoB gene, predominant nucleotide
changes and their correlation with high levels of resistance
to rifampicin in Mycobacterium tuberculosis isolates
that were randomly collected from sputa of 50 patients with
primary and secondary active pulmonary tuberculosis from the
southern TB endemic border of Iran. Drug susceptibility
testing was performed using the CDC standard conventional
proportional method. DNA extraction, rpoB gene
amplification, and DNA sequencing analysis were performed.
Thirty-nine (78%) isolates were found to have multiple
mutations (composed of two to five mutations) in the rpoB
(β-subunit) gene. Furthermore, it was demonstrated that the
combination of mutations with predominant nucleotide changes
were observed in codons 510, 523, 526 and 531, and indicated
higher frequencies of mutations among patients with
secondary infection. In this study, multiple mutated
isolates 76% (n = 38) were found to have mutation
combinations involving nucleotide changes in codons 523
(GGG→GCG),
531 (TCG→TTG,
TTC),
526 (CAC→CGC,
TTC, TAC, AAC, CAA), and demonstrated predominant mutations
in the last nine codons of the β-subunit (523 - 531) were
associated with higher levels of resistance to rifampicin (MIC
= ≥ 100 µg/ml).
Key
word: Multiple mutations, rpoB gene, M.
tuberculosis, high level resistance, Afghanistan border. |
|